{"@id":"https://bioecon.ru/technology/car-t-potentiation-via-mitochondria/","@type":"Technology","cluster":"regenerative-personalized","formats":{"html":"https://cn.bioecon.ru/technology/car-t-potentiation-via-mitochondria/","json":"https://cn.bioecon.ru/api/v1/technology/car-t-potentiation-via-mitochondria/index.json"},"id":"car-t-potentiation-via-mitochondria","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/johnson-johnson/","https://bioecon.ru/companies/san-diego-sa/","https://bioecon.ru/companies/impacfat/","https://bioecon.ru/companies/ingenio-risaralda-sa/","https://bioecon.ru/companies/wildtype/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/ipiranga-agroindustrial-sa/"]},"maturity":7,"name":"线粒体代谢强化型长效CAR-T免疫细胞疗法","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"超高完整度活性线粒体温和分离"},{"n":2,"title":"微流控高通量细胞器原位转移"},{"n":3,"title":"能量代谢谱重塑与储备呼吸能力确证"},{"n":4,"title":"体内抗肿瘤循环杀伤与抗耗竭验证"}],"summary":"将自健康干细胞分离出的高活性线粒体直接微量注射或受控转移至工程化CAR-T细胞内，从根源上重塑其代谢轴线并强化氧化磷酸化，彻底克服实体瘤微环境中的耗竭性失活。","url":"/technology/car-t-potentiation-via-mitochondria/","verified":"2026-11-22"}